The Phase II Trial has gone so well at American Family Children’s Hospital and 8 other health systems, the F.D.A. is fast-tracking the novel immunotherapy treatment approach. Quoted: Christian Capitini, assistant professor of pediatric hematology/oncology.
Office of Strategic Communication